David Paterson
Vermögen: - $ am 30.09.2026
Vermögen: - $ am 30.09.2026
Dr. David Paterson is an Independent Director at Sernova Biotherapeutics, Inc., an Assistant VP-Research Translation & Commercial at Colorado State University, a Director-Business Development at GlaxoSmithKline, Inc. and a Vice President-Business Development at Pacira Pharmaceuticals, Inc. (California).
He is on the Board of Directors at Sernova Biotherapeutics, Inc. Dr. Paterson was previously employed as a Co-Founder by Neurogastrx, Inc. and a Senior Director-Business Development by Sumitomo Pharma America, Inc. He also served on the board at Impax Laboratories (Netherlands) BV.
He received his undergraduate degree from the University of Glasgow and a doctorate degree from the University of Illinois.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.05.2026 | 0 ( -.--% ) | - $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Direktor/Vorstandsmitglied | 01.09.2024 |
Colorado State University
Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Develops and manufactures injectable and sustained release therapeutic products | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | - |
Impax Laboratories (Netherlands) BV
Impax Laboratories (Netherlands) BV Medical DistributorsDistribution Services Operates as a holding company whose subsidiaries wholesales pharmaceutical products | Direktor/Vorstandsmitglied | - |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Colorado State University
Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Develops and manufactures injectable and sustained release therapeutic products | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
Impax Laboratories (Netherlands) BV
Impax Laboratories (Netherlands) BV Medical DistributorsDistribution Services Operates as a holding company whose subsidiaries wholesales pharmaceutical products | Distribution Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen